{
    "article_link": "https://doi.org/10.1002/ctm2.1259",
    "data": [
        {
            "id": "data_1",
            "omics": "Proteomics",
            "link": "null",
            "format": "not specified",
            "source": "Proteomics Platform of Core Facility of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine (SJTU-SM)",
            "public_id": "null"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics",
            "link": "null",
            "format": "not specified",
            "source": "own dataset",
            "public_id": "null"
        },
        {
            "id": "data_3",
            "omics": "Clinical data",
            "link": "null",
            "format": "not specified",
            "source": "own dataset",
            "public_id": "null"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Proteotranscriptomic analysis",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Case-control analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Differential expression analysis between IgM-high and IgM-low EMZL subgroups",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "IgM_level": [
                    "high",
                    "low"
                ],
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Multivariate logistic regression",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Propensity score matching (PSM)",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Restricted cubic splines (RCS) analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "Receiver Operating Characteristic (ROC) analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "Nomogram construction",
            "analysis_data": [
                "data_3"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Absolute κ/λ score calculation",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "Venn plot of tumour-derived DEPs",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "Heatmap analysis of immunoglobulin constant regions",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        },
        {
            "id": "analysis_12",
            "analysis_name": "Principal Component Analysis (PCA)",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "diagnosis": [
                    "EMZL",
                    "nonmalignant diseases"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "Spearman correlation",
            "value": "0.56",
            "features": [
                "IGHM"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "log2(foldchange)",
            "value": "2.64",
            "features": [
                "IGHM"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "p-value",
            "value": "<0.001",
            "features": [
                "IGHM in proteome"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "p-value",
            "value": "<0.001",
            "features": [
                "IGHM in transcriptome"
            ]
        },
        {
            "analysis_id": "analysis_1",
            "metrics": "Threshold identification",
            "value": "Consistent dysregulation",
            "features": [
                "IGHM across subgroups in proteome and transcriptome"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "AUC",
            "value": "0.81",
            "features": [
                "serum IgM"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "p-value",
            "value": "<0.0001",
            "features": [
                "serum IgM decrease after treatment in EMZL"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "p-value",
            "value": "<0.0001",
            "features": [
                "serum IgM in EMZL vs. nonmalignant diseases"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "p-value",
            "value": "<0.0001",
            "features": [
                "serum IgM in EMZL vs. other subgroups"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "p-value",
            "value": "not significant",
            "features": [
                "serum IgM and Ki67"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "p-value",
            "value": "not significant",
            "features": [
                "serum IgM and Ann Arbor stage",
                "IPI score",
                "primary lymphoma site"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "p-value",
            "value": "not specified",
            "features": [
                "activated GPCR-related pathways",
                "WNT-related pathways",
                "interleukin 10-related pathways"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "p-value",
            "value": "0.002",
            "features": [
                "non-linear association of age with EMZL risk"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "cut-off_value",
            "value": "47 years",
            "features": [
                "age at diagnosis"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Spearman correlation",
            "value": "Negative",
            "features": [
                "serum IgM",
                "age in control and chronic inflammation groups"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "AUC",
            "value": "0.81",
            "features": [
                "PSM-adjusted serum IgM"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "cut-off_value",
            "value": "1.46 g/L",
            "features": [
                "serum IgM"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Specificity",
            "value": "0.897",
            "features": [
                "serum IgM cut-off 1.46 g/L"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Sensitivity",
            "value": "0.559",
            "features": [
                "serum IgM cut-off 1.46 g/L"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "cut-off_value",
            "value": "0.88 g/L",
            "features": [
                "serum IgM (minimal AIC)"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Specificity",
            "value": "0.560",
            "features": [
                "serum IgM cut-off 0.88 g/L"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Sensitivity",
            "value": "0.853",
            "features": [
                "serum IgM cut-off 0.88 g/L"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "AUC",
            "value": "0.81",
            "features": [
                "preEM score"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "Validation status",
            "value": "Validated",
            "features": [
                "preEM score in derivation and validation cohorts"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "Calibration agreement",
            "value": "Great agreement",
            "features": [
                "preEM predictions",
                "actual observations"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "AUC comparison",
            "value": "Higher than continuous/ordinal IgM",
            "features": [
                "preEM score"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "p-value",
            "value": "<0.001",
            "features": [
                "serum IgM"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "p-value",
            "value": "0.008",
            "features": [
                "age at diagnosis <47 years"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "p-value",
            "value": "not specified",
            "features": [
                "lacrimal gland involvement (selected via AIC)"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "monoclonality score",
            "value": "not specified",
            "features": [
                "serum IgM",
                "transcriptomic IgM"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "number of overlapping genes",
            "value": "2",
            "features": [
                "tumour-derived DEPs"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "expression pattern",
            "value": "Consistent dysregulation",
            "features": [
                "IGHM across subgroups in proteome and transcriptome"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "principal components",
            "value": "not specified",
            "features": [
                "high variant proteins",
                "high variant transcripts"
            ]
        }
    ]
}